Oral contraceptives & breast cancer:
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Washington, DC
National Acad. Press
1991
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | VIII, 185 S. graph. Darst. |
ISBN: | 0309044936 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV005450374 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | t | ||
008 | 920723s1991 d||| |||| 00||| engod | ||
020 | |a 0309044936 |9 0-309-04493-6 | ||
035 | |a (OCoLC)23869042 | ||
035 | |a (DE-599)BVBBV005450374 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-12 | ||
050 | 0 | |a RA645.C3 | |
082 | 0 | |a 616.99/449071 |2 20 | |
245 | 1 | 0 | |a Oral contraceptives & breast cancer |c Committee on the Relationship Between Oral Contraceptives and Breast Cancer, Institute of Medicine, Division of Health Promotion and Disease Prevention |
264 | 1 | |a Washington, DC |b National Acad. Press |c 1991 | |
300 | |a VIII, 185 S. |b graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
650 | 7 | |a Borstkanker |2 gtt | |
650 | 2 | |a Contraceptifs oraux - effets indésirables | |
650 | 7 | |a Epidemiologie |2 gtt | |
650 | 2 | |a Facteurs de risque | |
650 | 7 | |a Orale anticonceptiva |2 gtt | |
650 | 7 | |a Risico's |2 gtt | |
650 | 2 | |a Tumeurs du sein - induit chimiquement | |
650 | 4 | |a Breast Neoplasms |x chemically induced | |
650 | 4 | |a Breast |x Cancer |x Epidemiology |v Congresses | |
650 | 4 | |a Contraceptives, Oral |x adverse effects | |
650 | 4 | |a Oral contraceptives |x Side effects |v Congresses | |
650 | 4 | |a Risk Factors | |
650 | 0 | 7 | |a Brustkrebs |0 (DE-588)4008528-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Ovulationshemmer |0 (DE-588)4044229-9 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
689 | 0 | 0 | |a Ovulationshemmer |0 (DE-588)4044229-9 |D s |
689 | 0 | 1 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
689 | 0 | 2 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |D s |
689 | 0 | |5 DE-604 | |
856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003409007&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-003409007 |
Datensatz im Suchindex
_version_ | 1804119659336695808 |
---|---|
adam_text | G O ORAL CONTRACEPTIVES BREAST CANCER COMMITTEE ON THE RELATIONSHIP
BETWEEN ORAL CONTRACEPTIVES AND BREAST CANCER INSTITUTE OF MEDICINE
DIVISION OF HEALTH PROMOTION AND DISEASE PREVENTION NATIONAL ACADEMY
PRESS WASHINGTON, D.C. 1991 CONTENTS EXECUTIVE SUMMARY 1 MAINTAINING
SURVEILLANCE, 5 DEVELOPING A BROADER ARRAY OF CONTRACEPTIVES, 5
ASSESSING KNOWLEDGE FOR APPLICATION IN CLINICAL PRACTICE, 6 FILLING GAPS
IN BIOLOGICAL AND EPIDEMIOLOGICAL KNOWLEDGE, 7 INTRODUCTION AND OVERVIEW
9 BIOLOGICAL PLAUSIBILITY OF A LINK BETWEEN ORAL CONTRACEPTIVES AND
BREAST CANCER, 12 WHAT IS AND IS NOT*KNOWN, 13 SEEKING ANSWERS, 18
EPIDEMIOLOGY: INFORMATION NEEDS AND DATA GAPS 25 EPIDEMIOLOGICAL
RESEARCH, 25 CASE-CONTROL METHOD, 26; COHORT STUDIES, 27; COMPARISON
GROUPS, 28; ECOLOGICAL STUDIES, 28; SPECIAL STUDIES, 29; CHANGING ORAL
CONTRACEPTIVE FORMULATIONS, 33 SUMMARY AND CONCLUSIONS, 33 BIOLOGY:
INFORMATION NEEDS AND DATA GAPS 35 SIGNAL COMPLEXITY IN BREAST
REGULATION, 36 RESEARCH ISSUES, 38 RELATIONSHIPS AMONG CELL TYPES, 40;
RECEPTORS, 40; TIMING, 41; EFFECTS OF PREGNANCY AND LACTATION, 41; VN
VIII CONTENTS PATHOLOGICAL BREAST TISSUE, 42; ONCOGENES, 44; MOLECULAR
CHANGES ASSOCIATED WITH HUMAN BREAST CANCER, 45 RESEARCH MODELS, 48
BREAST CANCER CELL LINES, 49; SHORT-TERM CULTURE OF NORMAL MAMMARY
EPITHELIUM, 50; ORGAN CULTURE, 52; NUDE MOUSE MODEL, 53 SUMMARY AND
CONCLUSIONS, 53 4 INFORMATION FOR USERS OF THE PILL AND HEALTH CARE
PROVIDERS 55 BENEFITS AND RISKS OF ORAL CONTRACEPTIVES, 55 BENEFITS, 55;
RISKS, 57 CURRENT CONTROVERSY, 57 PRESCRIBING PROBLEMS, 59 5 POLICY
ISSUES AND RECOMMENDATIONS 61 MAINTAINING SURVEILLANCE, 61 COOPERATIVE
RESEARCH, 63; SURVEILLANCE REQUIREMENTS OF THE FOOD AND DRUG
ADMINISTRATION, 63 DEVELOPING A BROADER ARRAY OF CONTRACEPTIVES, 64
ASSESSING KNOWLEDGE FOR APPLICATION IN CLINICAL PRACTICE, 64 FILLING
GAPS IN BIOLOGICAL AND EPIDEMIOLOGICAL KNOWLEDGE, 65 REFERENCES 68
APPENDIXES A ORAL CONTRACEPTIVES AND BREAST CANCER: A REVIEW OF THE 75
EPIDEMIOLOGICAL EVIDENCE WITH AN EMPHASIS ON YOUNGER WOMEN (KATHLEEN E.
MALONE) B ORAL CONTRACEPTIVES AND BREAST CANCER: REVIEW OF THE 102
EPIDEMIOLOGICAL LITERATURE (DAVID B. THOMAS) C THE EVOLVING FORMULATIONS
OF ORAL CONTRACEPTIVES 143 D ANIMAL MODELS OF SEX STEROID HORMONES AND
MAMMARY CANCER: LESSONS FOR UNDERSTANDING STUDIES IN 152 HUMANS (DIANA
B. PETITTI) E RISKS AND BENEFITS OF ORAL CONTRACEPTIVES: WILL BREAST
CANCER TIP THE BALANCE? (DAVID C. G. SKEGG) 165 F LIST OF BACKGROUND
DOCUMENTS 175 INDEX 177
|
any_adam_object | 1 |
building | Verbundindex |
bvnumber | BV005450374 |
callnumber-first | R - Medicine |
callnumber-label | RA645 |
callnumber-raw | RA645.C3 |
callnumber-search | RA645.C3 |
callnumber-sort | RA 3645 C3 |
callnumber-subject | RA - Public Medicine |
ctrlnum | (OCoLC)23869042 (DE-599)BVBBV005450374 |
dewey-full | 616.99/449071 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.99/449071 |
dewey-search | 616.99/449071 |
dewey-sort | 3616.99 6449071 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02178nam a2200529 c 4500</leader><controlfield tag="001">BV005450374</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">920723s1991 d||| |||| 00||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309044936</subfield><subfield code="9">0-309-04493-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)23869042</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV005450374</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RA645.C3</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/449071</subfield><subfield code="2">20</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Oral contraceptives & breast cancer</subfield><subfield code="c">Committee on the Relationship Between Oral Contraceptives and Breast Cancer, Institute of Medicine, Division of Health Promotion and Disease Prevention</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, DC</subfield><subfield code="b">National Acad. Press</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII, 185 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Borstkanker</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Contraceptifs oraux - effets indésirables</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Epidemiologie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Facteurs de risque</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Orale anticonceptiva</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Risico's</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Tumeurs du sein - induit chimiquement</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast Neoplasms</subfield><subfield code="x">chemically induced</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Breast</subfield><subfield code="x">Cancer</subfield><subfield code="x">Epidemiology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Contraceptives, Oral</subfield><subfield code="x">adverse effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oral contraceptives</subfield><subfield code="x">Side effects</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Risk Factors</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Ovulationshemmer</subfield><subfield code="0">(DE-588)4044229-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Ovulationshemmer</subfield><subfield code="0">(DE-588)4044229-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003409007&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-003409007</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content |
genre_facet | Aufsatzsammlung Konferenzschrift |
id | DE-604.BV005450374 |
illustrated | Illustrated |
indexdate | 2024-07-09T16:29:42Z |
institution | BVB |
isbn | 0309044936 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-003409007 |
oclc_num | 23869042 |
open_access_boolean | |
owner | DE-12 |
owner_facet | DE-12 |
physical | VIII, 185 S. graph. Darst. |
publishDate | 1991 |
publishDateSearch | 1991 |
publishDateSort | 1991 |
publisher | National Acad. Press |
record_format | marc |
spelling | Oral contraceptives & breast cancer Committee on the Relationship Between Oral Contraceptives and Breast Cancer, Institute of Medicine, Division of Health Promotion and Disease Prevention Washington, DC National Acad. Press 1991 VIII, 185 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Borstkanker gtt Contraceptifs oraux - effets indésirables Epidemiologie gtt Facteurs de risque Orale anticonceptiva gtt Risico's gtt Tumeurs du sein - induit chimiquement Breast Neoplasms chemically induced Breast Cancer Epidemiology Congresses Contraceptives, Oral adverse effects Oral contraceptives Side effects Congresses Risk Factors Brustkrebs (DE-588)4008528-4 gnd rswk-swf Arzneimittelnebenwirkung (DE-588)4003134-2 gnd rswk-swf Ovulationshemmer (DE-588)4044229-9 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift gnd-content Ovulationshemmer (DE-588)4044229-9 s Brustkrebs (DE-588)4008528-4 s Arzneimittelnebenwirkung (DE-588)4003134-2 s DE-604 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003409007&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Oral contraceptives & breast cancer Borstkanker gtt Contraceptifs oraux - effets indésirables Epidemiologie gtt Facteurs de risque Orale anticonceptiva gtt Risico's gtt Tumeurs du sein - induit chimiquement Breast Neoplasms chemically induced Breast Cancer Epidemiology Congresses Contraceptives, Oral adverse effects Oral contraceptives Side effects Congresses Risk Factors Brustkrebs (DE-588)4008528-4 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd Ovulationshemmer (DE-588)4044229-9 gnd |
subject_GND | (DE-588)4008528-4 (DE-588)4003134-2 (DE-588)4044229-9 (DE-588)4143413-4 (DE-588)1071861417 |
title | Oral contraceptives & breast cancer |
title_auth | Oral contraceptives & breast cancer |
title_exact_search | Oral contraceptives & breast cancer |
title_full | Oral contraceptives & breast cancer Committee on the Relationship Between Oral Contraceptives and Breast Cancer, Institute of Medicine, Division of Health Promotion and Disease Prevention |
title_fullStr | Oral contraceptives & breast cancer Committee on the Relationship Between Oral Contraceptives and Breast Cancer, Institute of Medicine, Division of Health Promotion and Disease Prevention |
title_full_unstemmed | Oral contraceptives & breast cancer Committee on the Relationship Between Oral Contraceptives and Breast Cancer, Institute of Medicine, Division of Health Promotion and Disease Prevention |
title_short | Oral contraceptives & breast cancer |
title_sort | oral contraceptives breast cancer |
topic | Borstkanker gtt Contraceptifs oraux - effets indésirables Epidemiologie gtt Facteurs de risque Orale anticonceptiva gtt Risico's gtt Tumeurs du sein - induit chimiquement Breast Neoplasms chemically induced Breast Cancer Epidemiology Congresses Contraceptives, Oral adverse effects Oral contraceptives Side effects Congresses Risk Factors Brustkrebs (DE-588)4008528-4 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd Ovulationshemmer (DE-588)4044229-9 gnd |
topic_facet | Borstkanker Contraceptifs oraux - effets indésirables Epidemiologie Facteurs de risque Orale anticonceptiva Risico's Tumeurs du sein - induit chimiquement Breast Neoplasms chemically induced Breast Cancer Epidemiology Congresses Contraceptives, Oral adverse effects Oral contraceptives Side effects Congresses Risk Factors Brustkrebs Arzneimittelnebenwirkung Ovulationshemmer Aufsatzsammlung Konferenzschrift |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=003409007&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |